Site-Directed Mutations in the Lanthipeptide Mutacin 1140

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

(2012) Paul G. Arnison et al.   NATURAL PRODUCT REPORTS

Methodologies and Strategies for the Bioengineering of Lantibiotics

(2011) Jun-ichi Nagao et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Inhibiting the Initiation of Clostridium difficile Spore Germination using Analogs of Chenodeoxycholic Acid, a Bile Acid

(2010) J. A. Sorg et al.   JOURNAL OF BACTERIOLOGY

Optimization of the production of the lantibiotic mutacin 1140 in minimal media

(2010) Neeti Dahal et al.   PROCESS BIOCHEMISTRY

Subtilases: The superfamily of subtilisin-like serine proteases

(2010) Roland J. Siezen et al.   PROTEIN SCIENCE

Rapid method for extracting the antibiotic mutacin 1140 from complex fermentation medium yeast extract

(2009) Noel Chaney et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Lantibiotics: Mode of Action, Biosynthesis and Bioengineering

(2009) G. Bierbaum et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Pharmacokinetic and pharmacodynamic evaluation of the lantibiotic MU1140

(2009) Oliver Ghobrial et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Oxidation of Lanthionines Renders the Lantibiotic Nisin Inactive

(2008) S. Wilson-Stanford et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Elucidation of the Antimicrobial Mechanism of Mutacin 1140

(2008) Leif Smith et al.   BIOCHEMISTRY

Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics

(2008) Leif Smith et al.   CURRENT OPINION IN MICROBIOLOGY

Pharmacodynamic activity of the lantibiotic MU1140

(2008) Oliver G. Ghobrial et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The generation of nisin variants with enhanced activity against specific Gram-positive pathogens

(2008) Des Field et al.   MOLECULAR MICROBIOLOGY